21 CFR Part 58 · Good Laboratory Practice for Nonclinical Laboratory Studies

§ 58.31 Testing facility management

Subpart B - Organization and Personnel Official text on eCFR Amendment history

For each nonclinical laboratory study, testing facility management shall:

(a) Designate a study director as described in § 58.33 , before the study is initiated.

(b) Replace the study director promptly if it becomes necessary to do so during the conduct of a study.

(c) Assure that there is a quality assurance unit as described in § 58.35 .

(d) Assure that test and control articles or mixtures have been appropriately tested for identity, strength, purity, stability, and uniformity, as applicable.

(e) Assure that personnel, resources, facilities, equipment, materials, and methodologies are available as scheduled.

(f) Assure that personnel clearly understand the functions they are to perform.

(g) Assure that any deviations from these regulations reported by the quality assurance unit are communicated to the study director and corrective actions are taken and documented.

Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.

Warning letters citing § 58.31

5 FDA warning letters since 2017 cite this section :

FDA guidance that cites § 58.31

Amendment history

Federal Register documents that created or amended this section.